Ally Mohamed
Overview
Explore the profile of Ally Mohamed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishengoma D, Mandara C, Bakari C, Fola A, Madebe R, Seth M, et al.
Lancet Infect Dis
. 2024 Aug;
24(11):1225-1233.
PMID: 39159633
Background: In 2021, nationwide malaria molecular surveillance revealed a high prevalence of a validated artemisinin resistance marker, the kelch13 (k13) Arg561His mutation, in the Kagera region of northwestern Tanzania. We...
2.
Juliano J, Giesbrecht D, Simkin A, Fola A, Lyimo B, Pereus D, et al.
Lancet Microbe
. 2024 Aug;
5(10):100920.
PMID: 39159629
Background: The emergence of the artemisinin partial resistance (ART-R) mutation in the Plasmodium falciparum kelch13 gene (k13), Arg561His, in Rwanda and the regional presence of polymorphisms affecting sulfadoxine-pyrimethamine have raised...
3.
Ngasala B, Chiduo M, Mmbando B, Francis F, Bushukatale S, Makene T, et al.
Malar J
. 2024 Apr;
23(1):101.
PMID: 38594679
Background: Artemisinin-based combination therapy (ACT) has been a major contributor to the substantial reductions in global malaria morbidity and mortality over the last decade. In Tanzania, artemether-lumefantrine (AL) was introduced...
4.
Rogier E, Battle N, Bakari C, Seth M, Nace D, Herman C, et al.
Sci Rep
. 2024 Apr;
14(1):8158.
PMID: 38589477
Plasmodium falciparum with the histidine rich protein 2 gene (pfhrp2) deleted from its genome can escape diagnosis by HRP2-based rapid diagnostic tests (HRP2-RDTs). The World Health Organization (WHO) recommends switching...
5.
Ngasala B, Chiduo M, Bushukatale S, Mmbando B, Makene T, Kamugisha E, et al.
Malar J
. 2024 Apr;
23(1):95.
PMID: 38582830
Background: The use of artemisinin-based combination therapy (ACT) is recommended by the World Health Organization for the treatment of uncomplicated falciparum malaria. Artemether-lumefantrine (AL) is the most widely adopted first-line...
6.
Ngasala B, Bushukatale S, Chiduo M, Makene T, Mkony L, Mohamed A, et al.
Malar J
. 2024 Mar;
23(1):90.
PMID: 38553737
Background: Diversification of artemisinin-based combination therapy (ACT) is suggested as one of the strategies that can be used to contain artemisinin resistance. Artesunate-amodiaquine (ASAQ) is one of the artemisinin-based combinations...
7.
Ngasala B, Chacky F, Mohamed A, Molteni F, Nyinondi S, Kabula B, et al.
Am J Trop Med Hyg
. 2024 Mar;
110(5):887-891.
PMID: 38507797
As part of malaria nationwide monitoring and evaluation initiatives, there is an increasing trend of incorporating malaria rapid diagnostic tests (mRDTs) in surveys conducted within primary schools to detect malaria...
8.
Ishengoma D, Mandara C, Madebe R, Warsame M, Ngasala B, Kabanywanyi A, et al.
Malar J
. 2024 Mar;
23(1):79.
PMID: 38491359
Background: Tanzania is currently implementing therapeutic efficacy studies (TES) in areas of varying malaria transmission intensities as per the World Health Organization (WHO) recommendations. In TES, distinguishing reinfection from recrudescence...
9.
Bakari C, Mandara C, Madebe R, Seth M, Ngasala B, Kamugisha E, et al.
Malar J
. 2024 Mar;
23(1):71.
PMID: 38461239
Background: Therapeutic efficacy studies (TESs) and detection of molecular markers of drug resistance are recommended by the World Health Organization (WHO) to monitor the efficacy of artemisinin-based combination therapy (ACT)....
10.
Ishengoma D, Mandara C, Bakari C, Fola A, Madebe R, Seth M, et al.
medRxiv
. 2024 Feb;
PMID: 38352311
Background: Artemisinin-based combination therapies (ACTs) are the recommended antimalarial drugs for the treatment of uncomplicated malaria. The recent emergence of artemisinin partial resistance (ART-R) in Rwanda, Uganda and Eritrea is...